Related Experiment Video
Updated: May 6, 2026

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Examining public perceptions of cardiovascular disease risk screening programs in community pharmacies: a
Suha Alharbi1, Reem Almalki2, Shatha Almajnooni2
1Department of Pharmaceutical Practices, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. sskharbi@uqu.edu.sa.
Public acceptance of community pharmacy cardiovascular disease (CVD) screening in Saudi Arabia is positive, driven by trust in pharmacists and accessibility. Addressing privacy and cost concerns is key for successful implementation of these vital public health services.
Area of Science:
- Public Health
- Health Services Research
- Pharmacy Practice
Background:
- Cardiovascular diseases (CVDs) represent a major health challenge in Saudi Arabia, necessitating proactive risk management strategies.
- Community pharmacies (CPs) present an accessible platform for CVD risk screening, yet local initiatives are underdeveloped.
- Understanding public perceptions is crucial for the successful integration of pharmacy-based CVD screening services.
Purpose of the Study:
- To investigate public perceptions influencing the acceptance of community pharmacy-based cardiovascular disease (CVD) risk screening in Saudi Arabia.
- To identify key factors that encourage or hinder public engagement with pharmacy-based CVD screening services.
Main Methods:
- A convergent parallel mixed-methods approach utilized online questionnaires and semi-structured interviews.
- Quantitative data were analyzed descriptively, while qualitative data were subjected to framework analysis using the Health Belief Model (HBM).
Main Results:
- Over half of participants trusted pharmacists for CVD screening, with accessibility and convenience being significant motivators.
- Perceived susceptibility, severity, and self-efficacy, informed by the HBM, positively influenced acceptance.
- Concerns regarding privacy, cost, and pharmacy staffing levels emerged as notable barriers to service uptake.
Conclusions:
- Public attitudes towards community pharmacy CVD screening are generally favorable, supported by trust and perceived benefits.
- The Health Belief Model effectively explains the motivations and barriers influencing public engagement.
- Addressing privacy, cost, and staffing issues is critical for the successful implementation and expansion of these services.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Analysis of Population Pharmacokinetic Data
Peripheral Artery Disease III: Interprofessional Care